Almirall, S.A. (ALMRY)

CTI BioPharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	322.94	377.1	387.95	248.82	206.49	159.64
Short-Term Investments	0.28	0.2	0.14	-	0.81	5.95
Cash & Short-Term Investments	323.23	377.3	388.09	248.82	207.3	165.6
Cash Growth	-2.31%	-2.78%	55.97%	20.03%	25.18%	41.26%
Accounts Receivable	142.29	123.54	120.02	136.99	101.84	87.7
Other Receivables	51.5	49.53	27.02	22.09	59.89	96.24
Receivables	193.8	173.08	147.03	159.08	161.73	183.94
Inventory	179.69	171.78	167.53	130.1	118.63	130.15
Other Current Assets	17.34	18.99	16.01	14.72	11.62	10.06
Total Current Assets	714.05	741.14	718.66	552.72	499.27	489.75
Property, Plant & Equipment	186.47	166.46	151.64	144.61	123.81	122.97
Long-Term Investments	19.43	16.35	22.88	34.66	-	-
Goodwill	315.97	315.97	315.97	315.97	315.97	315.97
Other Intangible Assets	684.16	760.99	810.62	658.05	720.87	821.52
Long-Term Deferred Tax Assets	184.47	188.86	181.76	182.97	192.5	256.48
Long-Term Deferred Charges	116.38	108.14	85.75	80.1	72.14	35.36
Other Long-Term Assets	86.99	98.75	87.71	178.63	138.3	163.96
Total Assets	2,308	2,397	2,375	2,148	2,142	2,291
Accounts Payable	199.39	186.53	181.35	184.29	177.8	162.14
Accrued Expenses	30.23	38.62	30.15	30.79	-	29.69
Current Portion of Long-Term Debt	13.42	15.49	14.97	14.02	12.31	250.91
Current Portion of Leases	7.93	7.06	6.21	5.1	6.28	6.26
Current Income Taxes Payable	38.75	42.51	29.04	26.64	19.47	21.46
Other Current Liabilities	8.8	63.21	89.35	13.78	65.13	4.09
Total Current Liabilities	298.52	353.42	351.08	274.61	280.99	474.56
Long-Term Debt	328.57	332.99	341.85	350.76	359.69	229.98
Long-Term Leases	37.31	37.52	37.61	33.94	14.16	13.48
Long-Term Unearned Revenue	2.87	4.49	-	-	-	17.41
Long-Term Deferred Tax Liabilities	63.24	64.99	71.92	77.25	75.85	117.38
Other Long-Term Liabilities	56.02	56.29	48.65	38.37	47.12	49.69
Total Liabilities	844.82	908.28	911.59	828.98	855.71	988.15
Common Stock	25.77	25.62	25.13	21.78	21.57	21.37
Additional Paid-In Capital	596.08	581.87	545.87	317.32	295.79	273.89
Retained Earnings	30.85	14.42	-34.2	8.56	-36.58	78.47
Treasury Stock	-2.7	-2.78	-2.86	-2.55	-2.13	-2.26
Comprehensive Income & Other	813.1	869.25	929.46	973.61	1,007	931.5
Shareholders' Equity	1,463	1,488	1,463	1,319	1,286	1,303
Total Liabilities & Equity	2,308	2,397	2,375	2,148	2,142	2,291
Total Debt	387.23	393.07	400.63	403.81	392.45	500.64
Net Cash (Debt)	-64	-15.77	-12.54	-154.99	-185.15	-335.04
Net Cash Per Share	-0.30	-0.07	-0.06	-0.79	-1.02	-1.87
Filing Date Shares Outstanding	214.79	213.47	211.44	242.97	179.78	178.12
Total Common Shares Outstanding	214.79	213.47	211.44	242.97	179.78	178.12
Working Capital	415.54	387.72	367.59	278.11	218.28	15.19
Book Value Per Share	6.81	6.97	6.92	5.43	7.15	7.32
Tangible Book Value	462.98	411.42	336.82	344.7	249.2	165.48
Tangible Book Value Per Share	2.16	1.93	1.59	1.42	1.39	0.93
Land	109.77	102.75	96.29	96.58	96.26	95.68
Machinery	116.11	104.94	102.95	98.33	345.77	356.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.